A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients
Contributors
Derfuss, Tobias; Curtin, François; Guebelin, Claudia; Bridel, Claire
Published in
Multiple sclerosis, vol. 21, no. 7, p. 885-893Publication date
2015Abstract
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
DERFUSS, Tobias et al. A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients. In: Multiple sclerosis, 2015, vol. 21, n° 7, p. 885–893. doi: 10.1177/1352458514554052
Main files (1)
Article (Published version)
Identifiers
- PID : unige:45606
- DOI : 10.1177/1352458514554052
- PMID : 25392325
